Status:
RECRUITING
64Cu-DOTATATE-PET for Lyme Neuroborreliosis
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Borrelia Burgdorferi Neuroborreliosis
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The aim of the study is to investigate the applicability and performance of 64Cu-DOTATATE PET/CT/MR for diagnosis in patients with Lyme neuroborreliosis (LNB). In this prospective, observational coho...
Detailed Description
Background Imaging of neuroinfections is well documented, however with several restrictions due to the heterogeneity of pathogens. Lyme neuroborreliosis (LNB) is a tick-borne infection, caused by Bor...
Eligibility Criteria
Inclusion Criteria:
Age ≥ 18 years AND
- Clinical suspicion of LNB AND
- Must be able to read and understand the patient information and to give informed consent -
Exclusion Criteria:
- Pregnancy OR
- Breast-feeding OR
- Concluded antibiotic treatment OR
- Weight more than the maximum weight limit for the PET/CT/MRI bed of the scanner (140 kg) OR
- History of allergic reaction attributable to compounds of similar chemical or biologic composition to 64Cu-DOTATATE OR
- Contraindications to MR (check list) -
Key Trial Info
Start Date :
May 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06392815
Start Date
May 20 2024
End Date
December 31 2026
Last Update
May 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anne-Mette Lebech
Copenhagen, Capital Region, Denmark, 2100